Retension Pharmaceuticals (RTSN) Earnings Date, Estimates & Call Transcripts

Retension Pharmaceuticals logo
$12.90 +1.49 (+13.06%)
As of 12:46 PM Eastern

Retension Pharmaceuticals Earnings Summary

Retension Pharmaceuticals posted Q3 2026 earnings on November 18, 2026, reporting an EPS of -$7.33. With a trailing EPS of $0.00, Retension Pharmaceuticals' earnings are expected to grow next year, from ($6.24) to ($4.17) per share.

Q3 2026 Earnings Resources

Get Retension Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Retension Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Retension Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate
($6.24) EPS
Next Year EPS Consensus Estimate
($4.17) EPS

Retension Pharmaceuticals Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/18/2026---$7.33--$7.33--

Retension Pharmaceuticals Earnings - Frequently Asked Questions

Retension Pharmaceuticals (NASDAQ:RTSN) last announced its quarterly earning data on Wednesday, November 18, 2026. Learn more on RTSN's earnings history.

Retension Pharmaceuticals' earnings are expected to grow from ($6.24) per share to ($4.17) per share in the next year.


Earnings data for NASDAQ:RTSN is sourced from Fiscal.ai, with the most recent quarter reported on 11/18/2026. New results are added as companies report their earnings.
From Our Partners